This is not reducing US prices, but delaying the launch in Europe. Reuters report:
Since Trump’s executive order, drug launches in EU markets have declined by nearly 35% compared to the previous 10 months… Delaying launches at lower EU prices could help protect against higher US prices in the long run.
You can read the full article Here.
